相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glutamate in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: A Meta-analysis of 1H-Magnetic Resonance Spectroscopy Studies
Jakob Kaminski et al.
BIOLOGICAL PSYCHIATRY (2021)
Glutathione and glutamate in schizophrenia: a 7T MRS study
Jyothika Kumar et al.
MOLECULAR PSYCHIATRY (2020)
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2020)
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi et al.
NATURE COMMUNICATIONS (2020)
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
Valerie J. Sydnor et al.
SCHIZOPHRENIA RESEARCH (2020)
Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Manabu Kubota et al.
SCHIZOPHRENIA RESEARCH (2020)
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
Steven G. Potkin et al.
NPJ SCHIZOPHRENIA (2020)
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia
Meredith A. Reid et al.
SCHIZOPHRENIA BULLETIN (2019)
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study
Yusuke Iwata et al.
BIOLOGICAL PSYCHIATRY (2019)
Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
Anna M. Wang et al.
JAMA PSYCHIATRY (2019)
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Robert McCutcheon et al.
SCHIZOPHRENIA BULLETIN (2018)
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
Sameer Jauhar et al.
LANCET PSYCHIATRY (2018)
Ultra-High-Field Magnetic Resonance Spectroscopy in Psychiatry
Beata P. Godlewska et al.
FRONTIERS IN PSYCHIATRY (2017)
Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research
Maria R. Dauvermann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid,Glutamate,and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings
Katharine N. Thakkar et al.
BIOLOGICAL PSYCHIATRY (2017)
Chronic Cigarette Smoking in Healthy Middle-Aged Individuals Is Associated With Decreased Regional Brain N-acetylaspartate and Glutamate Levels
Timothy C. Durazzo et al.
BIOLOGICAL PSYCHIATRY (2016)
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A 1H MRS Study at 7 Tesla
Allison S. Brandt et al.
SCHIZOPHRENIA RESEARCH (2016)
Nature of Glutamate Alterations in Schizophrenia A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies
Kate Merritt et al.
JAMA PSYCHIATRY (2016)
Elevated brain lactate in schizophrenia: a 7T magnetic resonance spectroscopy study
L. M. Rowland et al.
TRANSLATIONAL PSYCHIATRY (2016)
Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
Elias Mouchlianitis et al.
LANCET PSYCHIATRY (2016)
Neurochemistry of major depression: a study using magnetic resonance spectroscopy
Beata R. Godlewska et al.
PSYCHOPHARMACOLOGY (2015)
Power failure: why small sample size undermines the reliability of neuroscience
Katherine S. Button et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Regional neurochemical profiles in the human brain measured by 1H MRS at 7 T using local B1 shimming
Uzay E. Emir et al.
NMR IN BIOMEDICINE (2012)
Review of the operational definition for first-episode psychosis
Nicholas J. K. Breitborde et al.
EARLY INTERVENTION IN PSYCHIATRY (2009)
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies
David A. Lewis et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
Richard S. E. Keefe et al.
SCHIZOPHRENIA RESEARCH (2008)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer
Lasse K. Bak et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
RSE Keefe et al.
SCHIZOPHRENIA RESEARCH (2004)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)
A revised excitotoxic hypothesis of schizophrenia: Therapeutic implications
SI Deutsch et al.
CLINICAL NEUROPHARMACOLOGY (2001)
分享论文
